Tue, May 1, 2012
Mon, April 30, 2012
[ Mon, Apr 30th 2012 ]: Market Wire
Hologic to Acquire Gen-Probe
Sun, April 29, 2012
Sat, April 28, 2012
Fri, April 27, 2012
Thu, April 26, 2012
Wed, April 25, 2012
Tue, April 24, 2012
Mon, April 23, 2012
Sun, April 22, 2012
Sat, April 21, 2012
Fri, April 20, 2012
Thu, April 19, 2012
Wed, April 18, 2012
Tue, April 17, 2012
[ Tue, Apr 17th 2012 ]: Market Wire
Galapagos gives R&;;D update

Law Office of Brodsky amp;; Smith, LLC Announces Investigation of Ardea Biosciences, Inc.


  Copy link into your clipboard //health-fitness.news-articles.net/content/2012/ .. nces-investigation-of-ardea-biosciences-inc.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

Law Office of Brodsky & Smith, LLC Announces Investigation of Ardea... -- BALA CYNWYD, Pa., April 24, 2012 /PRNewswire/ --

Law Office of Brodsky & Smith, LLC Announces Investigation of Ardea Biosciences, Inc.

[ ]

BALA CYNWYD, Pa., April 24, 2012 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Ardea Biosciences, Inc. ("Ardea" or the "Company") (NASDAQ: [ RDEA ]) relating to the proposed acquisition by AstraZeneca.

Under the terms of the transaction, Ardea shareholders would receive only $32.00 in cash for each share of Ardea stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Ardea for not acting in the Company's shareholders' best interests in connection with the sale process to AstraZeneca. The transaction may undervalue Ardea as the Company's key product "lesunirad" is currently in a phase III development as a potential drug for chronic management of hyperuricaemia.  In addition, an analyst has set a price target on Ardea stock at $40.00 per share.

If you own shares of Ardea stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions.  You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at [ investorrelations@brodsky-smith.com ], visiting [ http://brodsky-smith.com/414-rdea-ardea-biosciences-inc.html ], or by calling toll free 877-LEGAL-90.

SOURCE Brodsky & Smith, LLC

[ Back to top ]

RELATED LINKS
[ http://www.brodsky-smith.com ]


Publication Contributing Sources